Aurinia Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
14315 118 Ave NW 140, Edmonton, Alberta,...Phone Number
(250) 744-2487Website
www.auriniapharma.comRevenue
$311.5 MillionStock Symbol
AUPHIndustry
About Aurinia Pharmaceuticals
Aurinia Pharmaceuticals a clinical-stage biopharmaceutical company develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis.Explore more
Aurinia Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aurinia Pharmaceuticals
Compare insights from companies similar to Aurinia Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aurinia Pharmaceuticals Tech Stack
A closer look at the technologies used by Aurinia Pharmaceuticals
Top Manufacturing Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Aurinia Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Aurinia Pharmaceuticals a clinical-stage biopharmaceutical company develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis.... Read More
